文献速递呼吸衰竭与机械通气重症综合管理与镇静镇痛

有创机械通气患者入住重症监护室的医院与地区差异

Hospital and regional variations in intensive care unit admission for patients with invasive mechanical ventilation.
PubMed 文献 · J Intensive Care · 2024-06-05
一句话结论日本全国数据显示,有创机械通气患者是否入住ICU主要由医院和地区因素决定,而非患者因素,医院和地区层面的ICC分别高达82.2%和67.3%。

该回顾性队列研究利用日本全国住院行政数据库和医疗设施统计,纳入2018年4月至2019年3月期间接受有创机械通气的≥15岁患者83,346例,来自546家医院、140个地区。主要结局为有创机械通气启动当天入住ICU,40.4%的患者在通气启动当天在ICU治疗。多水平分析显示医院聚类(ICC 82.2%,MOR 41.4)和地区聚类(ICC 67.3%,MOR 12.0)效应显著,纳入患者层面变量后ICC和MOR基本不变(PCV分别为2.3%和-1.0%);进一步调整医院和地区层面变量后ICC和MOR下降(PCV分别为95.2%和85.6%),其中有ICU床位的医院和有ICU床位的地区与ICU入住呈统计学显著且强的关联。结论提示医院和地区因素而非患者因素主要影响有创机械通气患者的ICU入住,对医疗政策制定者规划ICU资源分配有重要意义。

要点

  • 在有创机械通气启动当天,仅40.4%的患者入住ICU,医院间ICU入住率中位数为0.7%(四分位距0-44.5%),地区间中位数为28.7%(四分位距0.9-46.2%)。
  • 医院聚类效应显著:ICC 82.2%,MOR 41.4;地区聚类效应显著:ICC 67.3%,MOR 12.0。
  • 纳入患者层面变量后ICC和MOR基本不变(PCV分别为2.3%和-1.0%),提示患者因素解释力有限。
  • 进一步调整医院和地区层面变量后,ICC和MOR下降(PCV分别为95.2%和85.6%),其中有ICU床位的医院和有ICU床位的地区与ICU入住呈统计学显著且强的关联。
  • 作者认为,医院和地区因素而非患者相关因素主要阻碍有创机械通气患者入住ICU,对医疗政策制定者规划最佳ICU资源分配有重要启示。

适用人群与场景

  • 年龄≥15岁、在2018年4月至2019年3月期间接受有创机械通气的患者,数据来自日本全国住院行政数据库和医疗设施统计,共83,346例,来自546家医院、140个地区。

研究设计与关键结果

  • 研究类型为回顾性队列研究,使用日本全国住院行政数据库和医疗设施统计,纳入2018年4月至2019年3月期间接受有创机械通气的≥15岁患者83,346例,来自546家医院、140个地区。
  • 主要结局为有创机械通气启动当天入住ICU:40.4%的患者在通气启动当天在ICU治疗。
  • 医院间ICU入住率中位数为0.7%(四分位距0-44.5%),地区间中位数为28.7%(四分位距0.9-46.2%)。
  • 多水平分析显示医院聚类效应显著:ICC 82.2%,MOR 41.4;地区聚类效应显著:ICC 67.3%,MOR 12.0。
  • 纳入患者层面变量后,ICC和MOR基本不变,PCV分别为2.3%和-1.0%。
  • 进一步调整医院和地区层面变量后,ICC和MOR下降,PCV分别为95.2%和85.6%;其中有ICU床位的医院和有ICU床位的地区与ICU入住呈统计学显著且强的关联。

证据类型、等级与局限

  • 证据类型:回顾性队列研究,使用全国性行政数据库。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,医院和地区因素而非患者相关因素主要阻碍有创机械通气患者入住ICU,对医疗政策制定者规划最佳ICU资源分配有重要启示。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Patients who receive invasive mechanical ventilation (IMV) in the intensive care unit (ICU) have exhibited lower in-hospital mortality rates than those who are treated outside. However, the patient-, hospital-, and regional factors influencing the ICU admission of patients with IMV have not been quantitatively examined.

METHODS: This retrospective cohort study used data from the nationwide Japanese inpatient administrative database and medical facility statistics. We included patients aged ≥ 15 years who underwent IMV between April 2018 and March 2019. The primary outcome was ICU admission on the day of IMV initiation. Multilevel logistic regression analyses incorporating patient-, hospital-, or regional-level variables were used to assess cluster effects by calculating the intraclass correlation coefficient (ICC), median odds ratio (MOR), and proportional change in variance (PCV).

RESULTS: Among 83,346 eligible patients from 546 hospitals across 140 areas, 40.4% were treated in ICUs on their IMV start day. ICU admission rates varied widely between hospitals (median 0.7%, interquartile range 0-44.5%) and regions (median 28.7%, interquartile range 0.9-46.2%). Multilevel analyses revealed significant effects of hospital cluster (ICC 82.2% and MOR 41.4) and regional cluster (ICC 67.3% and MOR 12.0). Including patient-level variables did not change these ICCs and MORs, with a PCV of 2.3% and - 1.0%, respectively. Further adjustment for hospital- and regional-level variables decreased the ICC and MOR, with a PCV of 95.2% and 85.6%, respectively. Among the hospital- and regional-level variables, hospitals with ICU beds and regions with ICU beds had a statistically significant and strong association with ICU admission.

CONCLUSIONS: Our results revealed that primarily hospital and regional factors, rather than patient-related ones, opposed ICU admissions for patients with IMV. This has important implications for healthcare policymakers planning interventions for optimal ICU resource allocation.

来源:J Intensive Care,查看原文。版权归原作者所有。

参考来源

  1. Ohbe H, Shime N, Yamana H, et al. Hospital and regional variations in intensive care unit admission for patients with invasive mechanical ventilation. J Intensive Care. 2024. PMID: 38840225. doi:10.1186/s40560-024-00736-0

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。